June 21-22, 2018

Next Gen Immuno-Oncology Congress

Philadelphia - USA
37+
Speakers
200+
Attendees
7
Sessions

The next big question in cancer immunotherapy is what’s next in immuneoncology?
Overcoming resistance to various combinatorial approaches, selecting the patients and developing translational hypothesis besides designing optimal preclinical models for immunological agents, different strategies to regulate the microbiome are some of the major challenges faced by cancer research experts in the US.

Following the success of our UK Edition, MarketsandMarkets is proud to announce the Next Gen Immuno-Oncology Congress-US Edition to be held on 21st and 22nd June 2018 in Philadelphia, USA. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiomederived immunotherapy and new paradigms in immune checkpoint inhibitors

users

The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiomederived immunotherapy and new paradigms in immune checkpoint inhibitors.

users

Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

users

With more than 35+ speakers at the congress, they will focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in celluar and viral therapies, vaccines development and personalized immunotherapy.

This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

 

Register for our 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress 2020, write an email to events@marketsandmarkets.com

WHAT TO EXPECT
CONFERENCE SPEAKERS
Advisors
Stefan Glueck

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
John Delaney

John Delaney

Executive Director, Research
Amgen

John Delaney

Executive Director, Research
Amgen
Speakers
Eytan Barnea

Eytan Barnea

Founder and Chief Scientist
BioIncept LLC

Eytan Barnea

Founder and Chief Scientist
BioIncept LLC
Ellen Pure

Ellen Pure

Professor and Chair, Department of Biomedical Sciences
University of Pennsylvania

Ellen Pure

Professor and Chair, Department of Biomedical Sciences
University of Pennsylvania
Terry Fisher

Terry Fisher

Director, Translational Science and Bioanalytical
Vaccinex

Terry Fisher

Director, Translational Science and Bioanalytical
Vaccinex
Judi Wardwell-Swanson

Judi Wardwell-Swanson

Senior Application Scientist
Insphero

Judi Wardwell-Swanson

Senior Application Scientist
Insphero
Pirouz Daftarian

Pirouz Daftarian

Application Manager, IO/Vaccines
MBL International /JSR Micro, Life Sciences Inc.

Pirouz Daftarian

Application Manager, IO/Vaccines
MBL International /JSR Micro, Life Sciences Inc.
Raj Chavali

Raj Chavali

Senior Director
Caris Lifesciences

Raj Chavali

Senior Director
Caris Lifesciences
Joost Oppenheim

Joost Oppenheim

Head, Cellular Immunology
NIH

Joost Oppenheim

Head, Cellular Immunology
NIH
Christophe Queva

Christophe Queva

Chief Scientific Officer
Oncorus

Christophe Queva

Chief Scientific Officer
Oncorus
Ashok Shrivastava

Ashok Shrivastava

CEO
Cure Pharmaceuticals

Ashok Shrivastava

CEO
Cure Pharmaceuticals
Mark Gardner

Mark Gardner

CEO
OmniSeq

Mark Gardner

CEO
OmniSeq
Patrick Hanley

Patrick Hanley

Director, GMP for Immunotherapy, Assistant Professor
Children’s National Medical Centre

Patrick Hanley

Director, GMP for Immunotherapy, Assistant Professor
Children’s National Medical Centre
Frank Walsh

Frank Walsh

CEO
Ossianix Inc.

Frank Walsh

CEO
Ossianix Inc.
Mithun Khattar

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology
Lata Jayaraman

Lata Jayaraman

Head, Tumor Immunotherapy
Seres Therapeutics

Lata Jayaraman

Head, Tumor Immunotherapy
Seres Therapeutics
Gregory Alberts

Gregory Alberts

Global Subject Matter Expert
Lonza Pharma Bioscience Solutions

Gregory Alberts

Global Subject Matter Expert
Lonza Pharma Bioscience Solutions
Mark Paris

Mark Paris

Associate Director, Translational Applications
Mitra Biotech

Mark Paris

Associate Director, Translational Applications
Mitra Biotech
Holly Koblish

Holly Koblish

Director, Pharmacology
ncyte

Holly Koblish

Director, Pharmacology
ncyte
Papia Chakraborty

Papia Chakraborty

Senior Scientist, Head, Immuno-Oncology
Medgenome

Papia Chakraborty

Senior Scientist, Head, Immuno-Oncology
Medgenome
Pramod Srivastava

Pramod Srivastava

Director of the Carole and Ray Neag Comprehensive Cancer Cente
University of Connecticut

Pramod Srivastava

Director of the Carole and Ray Neag Comprehensive Cancer Cente
University of Connecticut
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
John Delaney

John Delaney

Executive Director, Research
Amgen

John Delaney

Executive Director, Research
Amgen
Ildiko Csiki

Ildiko Csiki

Vice President, Clinical Development Immuno- Oncology
Inovio

Ildiko Csiki

Vice President, Clinical Development Immuno- Oncology
Inovio
Ezio Bonvini

Ezio Bonvini

Senior Vice President, CSO
MacroGenics

Ezio Bonvini

Senior Vice President, CSO
MacroGenics
Stephen Schoenberger

Stephen Schoenberger

Professor of Immunology
La Jolla Institute for Allergy and Immunology

Stephen Schoenberger

Professor of Immunology
La Jolla Institute for Allergy and Immunology
Andrew Allen

Andrew Allen

CEO
Gritstone Oncology

Andrew Allen

CEO
Gritstone Oncology
Wei Zhou

Wei Zhou

Senior Research Scientist
The Jackson Laboratory

Wei Zhou

Senior Research Scientist
The Jackson Laboratory
Rakesh Dixit

Rakesh Dixit

CEO
Bionavigen

Rakesh Dixit

CEO
Bionavigen
Stefan Glueck

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene
Daniel Powell

Daniel Powell

Associate Professor of Pathology and Laboratory Medicine
University of Pennsylvania

Daniel Powell

Associate Professor of Pathology and Laboratory Medicine
University of Pennsylvania
Daniel Levey

Daniel Levey

Senior Director Vaccine Research
Agenus

Daniel Levey

Senior Director Vaccine Research
Agenus
Wendy Clemens

Wendy Clemens

Vice President, Clinical Development
Nektar Therapeutics

Wendy Clemens

Vice President, Clinical Development
Nektar Therapeutics
Natalie Russi

Natalie Russi

Scientific Project Manager
Nebion

Natalie Russi

Scientific Project Manager
Nebion
Lisa McNeil

Lisa McNeil

Director, Translational Medicine
Genocea

Lisa McNeil

Director, Translational Medicine
Genocea
Wayne Godfrey

Wayne Godfrey

Senior Director, Clinical Development
Kite Pharma

Wayne Godfrey

Senior Director, Clinical Development
Kite Pharma
Liang Deng

Liang Deng

Associate Member, Attending Physician
Memorial Sloan Kettering Cancer Centre

Liang Deng

Associate Member, Attending Physician
Memorial Sloan Kettering Cancer Centre
Christopher Bunker

Christopher Bunker

Vice President, Business Development
ACD-Bio-Biotechne

Christopher Bunker

Vice President, Business Development
ACD-Bio-Biotechne
SPONSORS
Gold Sponsors
example-image

Lonza

Silver Sponsors
example-image

PBL Assay Science

example-image

Mitra Biotech

example-image

Advanced Cell Diagnostics

Sponsors & Exhibitors
example-image

Caris Life Sciences

example-image

InSphero

example-image

Cytek

example-image

Nebion

example-image

MBL International Corporation

example-image

ACEA Biosciences

example-image

MedGenome Inc

example-image

Studylog

example-image

STEMCELL Technologies

example-image

Ossianix

PARTNERS
Supporting Association
example-image

Colorado BioScience Association

Media Partners
example-image

Immuno-Oncology News

example-image

Technology Networks

example-image

SciDoc Publishers

LOCATION
Philadelphia - USA

Please contact us on events@marketsandmarkets.com to get hotel booking link.

About the Hotel

Radisson Hotel Philadelphia Northeast,
Philadelphia-USA

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

PAST EVENT GALLERY